Wall Street

Did Sarepta Therapeutics Just Unveil a Breakthrough?

Published by
The Street

By Maxx Chatsko The leading gene therapy developer just bolstered its technology platform. Delivery is important. It matters for e-commerce, the space economy, pizza night, and especially drug development. That’s what makes a recent announcement from Sarepta Therapeutics (SRPT) – Get Sarepta Therapeutics Inc. Report worth a closer look by investors. As one of the leading genetic medicine companies on the planet, Sarepta Therapeutics is on the forefront of many nerdy advances. It was the first drug developer to earn U.S. Food and Drug Administration (FDA) approval for products treating Duchenne…

Read More

Share this Story
Load More Related Articles
Load More In Wall Street